ATE366579T1 - Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin - Google Patents

Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin

Info

Publication number
ATE366579T1
ATE366579T1 AT04710040T AT04710040T ATE366579T1 AT E366579 T1 ATE366579 T1 AT E366579T1 AT 04710040 T AT04710040 T AT 04710040T AT 04710040 T AT04710040 T AT 04710040T AT E366579 T1 ATE366579 T1 AT E366579T1
Authority
AT
Austria
Prior art keywords
nemorubicin
liver cancer
treating liver
intrahepatic administration
intrahepatic
Prior art date
Application number
AT04710040T
Other languages
English (en)
Inventor
Olga Valota
Maria Pacciarini
Original Assignee
Nerviano Medical Sciences Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerviano Medical Sciences Srl filed Critical Nerviano Medical Sciences Srl
Application granted granted Critical
Publication of ATE366579T1 publication Critical patent/ATE366579T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04710040T 2003-02-26 2004-02-11 Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin ATE366579T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03100470 2003-02-26

Publications (1)

Publication Number Publication Date
ATE366579T1 true ATE366579T1 (de) 2007-08-15

Family

ID=32921607

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04710040T ATE366579T1 (de) 2003-02-26 2004-02-11 Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin

Country Status (8)

Country Link
US (1) US20060264388A1 (de)
EP (1) EP1596874B1 (de)
JP (1) JP2006519209A (de)
AT (1) ATE366579T1 (de)
DE (1) DE602004007491T2 (de)
ES (1) ES2289483T3 (de)
TW (1) TW200501967A (de)
WO (1) WO2004075904A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100464783C (zh) * 2004-11-22 2009-03-04 山东蓝金生物工程有限公司 一种含抗肿瘤抗生素的抗癌药物组合物
WO2008138758A1 (en) 2007-05-11 2008-11-20 Nerviano Medical Sciences S.R.L. Pharmaceutical composition of an anthracycline
US8591921B2 (en) 2008-04-10 2013-11-26 Virginia Commonwealth University Induction of tumor hypoxia for cancer therapy
FR2992863B1 (fr) 2012-07-06 2014-08-29 Chu De Dijon Composition pharmaceutique pour le traitement du cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820012D0 (en) * 1998-09-14 1998-11-04 Pharmacia & Upjohn Spa Use of an anthracycline derivative for the treatment of a liver tumor
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives

Also Published As

Publication number Publication date
EP1596874A1 (de) 2005-11-23
ES2289483T3 (es) 2008-02-01
WO2004075904A1 (en) 2004-09-10
EP1596874B1 (de) 2007-07-11
DE602004007491D1 (de) 2007-08-23
US20060264388A1 (en) 2006-11-23
TW200501967A (en) 2005-01-16
DE602004007491T2 (de) 2008-03-13
JP2006519209A (ja) 2006-08-24

Similar Documents

Publication Publication Date Title
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
DE60215787D1 (de) Behandlung von typ ii diabetes mit dipeptidyl-peptidase-iv-hemmern
NO20053077L (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
DE60331537D1 (de) Kombinationen zur behandlung von multiplem myelom
DE60234577D1 (de) Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
ATE516819T1 (de) Verfahren zur behandlung von b-zell-bedingtem krebs
DE60324427D1 (de) Verfahren zur modulation der tubulindeacetylase-aktivität
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
DE602004002394D1 (de) (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN
ATE353645T1 (de) Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia
ATE439833T1 (de) Pharmazeutische zubereitung enthaltend ein catechin, ascorbinsäure, prolin und lysin zur behandlung von neoplastischen krankheiten
ATE353650T1 (de) Kombinationstherapie zur behandlung von krebs
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
DE602004024221D1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
ATE366579T1 (de) Verfahren zur behandlung von leberkrebs durch intrahepatische verabreichung von nemorubicin
EA200501865A1 (ru) Аналоги тиовольфраматов и их применение
ATE421882T1 (de) Schnellösliches azithromycin in einzeldosisform
ATE502637T1 (de) Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum
TW200635609A (en) Novel pharmaceutical composition containing at least one dolastatin 10 derivative
ATE540920T1 (de) Aminobenzocycloheptenderivate, verfahren zu deren herstellung und deren verwendung in der therapie
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
DE60313344D1 (de) Verwendung von 4-pyridylmethyl-phthalazin-derivaten zur herstellung eines medikaments zur behandlung von myelodysplastischen syndromen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1596874

Country of ref document: EP

REN Ceased due to non-payment of the annual fee